By contrast, little is known about the significance of GSK-3β in B-cell lymphoma pathogenesis, resistance to therapy, and survival despite its known function as a metabolic checkpoint regulator in B-cells [23]. The gene discussed is GSK3B; the disease is B-cell non-Hodgkin lymphoma.